The cardiac functional affection by trimetazidine administration plus bone marrow stem cells transplanting in rats after myocardial infarction
10.3760/cma.j.issn.1004-4477.2009.11.020
- VernacularTitle:曲美他嗪改善移植微环境对心肌梗死大鼠左心功能的影响
- Author:
Hongxin XU
;
Yihao TIAN
;
Hong JIANG
;
Xuejun JIANG
;
Qing ZHOU
;
Ruiqiang GUO
- Publication Type:Journal Article
- Keywords:
Echocardiography;
Stem cell transplantation;
Myocardial infarction;
Ventricular function;
left;
Trirnetazidine
- From:
Chinese Journal of Ultrasonography
2009;18(11):973-976
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the rat cardiac size and cardiac function changes before and after trimetazidine administration plus bone-marrow stem cells transplanting through echocardiography.Methods Forty wistar rats were divided into the following 4 groups randomly:control group (T),myocardial infarction group (Ⅱ),bone marrow stem calls transplantation group (Ⅲ),and bone marrow stem cells transplantation plus trimetazidine administration group(Ⅳ).The rats' left anterior coronary artery in group Ⅱ,Ⅲ and Ⅳwas ligated to produce myocardial infarction model,then bone-marrow stem cells were injected around the infarcted area into the later two groups.Furthermore,rats in group Ⅳ were administrated with trimetazidine.The size and systolic function of the hearts were measured 4 weeks after transplantation.The left ventricular systolic pressure(LVSP) and the end-diastolic pressure(LVEDP) were also measured at the end of experiment.Results The left ventricular diameter of rats in group Ⅲ and Ⅳ was smaller than that in group Ⅱ,and the ventricular systolic function increased,LVSP increased and LVEDP decreased statistically in group Ⅲ and Ⅳ.the amelioration of cardiac size and function was significantly notable in group Ⅳ than that in group Ⅲ.Conclusions Bone marrow stem cells transplantation can release the enlargement of left ventricle and improve cardiac function after myocardial infarction.The therapeutic efficacy can be further elevated if administrated with trimetazidine simultaneously.